HIV-infection Response

1. Support and Stigma Reduction

1.1. Counseling and support services

1.2. Stigma reduction campaigns

1.3. Community engagement

2. Prevention

2.1. Education and awareness

2.2. Pre-exposure prophylaxis (PrEP)

2.3. Post-exposure prophylaxis (PEP)

2.4. Safe sex practices

2.5. Needle exchange programs

2.6. Mother-to-child transmission programs

3. Priority Populations

3.1. Men who have sex with men (MSM)

3.2. Female sex workers (FSW)

3.3. People who inject drugs (PWID)

3.4. Transgender people (TG)

3.5. PLHIV

3.6. Non-KP

4. Social Support and Assistance

4.1. Housing assistance

4.2. Financial assistance

4.3. Food assistance

4.4. Legal assistance

4.5. Mental health support

4.6. Linkage to medical care

5. Research and Development

5.1. Vaccine development

5.2. Treatment development

5.3. Testing assays development

5.4. New surveillance methods research

5.5. Prevention methods development

5.6. Educational strategies developmetn

5.7. Support and stigma reduction methods Development

5.8. Social Support methods development

6. Testing and Diagnosis

6.1. Voluntary testing

6.2. Facility testing

6.3. Social network testing

6.4. Index testing

6.5. Recency testing

6.6. Self-testing

6.7. Clinical and laboratory monitoring

7. Treatment

7.1. Antiretroviral therapy (ART)

7.2. Treatment as prevention (TasP)

7.3. Opportunistic infection treatment

7.4. Adherence to treatment

8. Surveillance

8.1. Routine

8.2. Biobehavioral

8.3. Biological

8.4. Modelling

9. Program Impact

9.1. Epidemic control

9.2. Health outcomes

9.3. Quality of life

9.4. Life expectancy